#AwareHIV: HIV Indicator Diseases in Hospital and Primary Care

Sponsor
Erasmus Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05225493
Collaborator
Huisartspraktijk Gezondheidscentrum Mathenesserlaan (Other), TU Delft department of Artificial Intelligence and MyTomorrows (Other), Huisartsen Groep Rotterdam (Other), AwareHIV Project Group (Other), Huisartspraktijk Handellaan (Other), Huisartspraktijk Leerdam (Other), Huisartspraktijk Capelle ad IJssel (Other), Leiden University Medical Center (Other), Maasstadziekenhuis (Other), Rijnstate Hospital (Other), Medical Center Haaglanden (Other)
1,500
1
52
28.9

Study Details

Study Description

Brief Summary

Patients are frequently evaluated by physicians for medical work-up of HIV indicator conditions in hospital and in primary care at the general practitioner. Testing for HIV is indicated with HIV indicator disorder but often omitted in clinical work-up. Besides the fact that HIV testing is forgotten, there are other reasons such as an underestimation of the risk of HIV in the event of indicator disorders, stigma and difficulties in discussing the test with a patient. Also and more relevant for primary care than for the hospital, practical challenges can exist for a patient to go to a laboratory, or costs are a hurdle.

This project focuses on improving HIV indicator condition driven testing in different settings of the HIV epidemic, initially in the Netherlands as low HIV prevalence setting followed by an assessment of its benefit in different international settings. A specific focus will also be on the Rotterdam area in the Netherlands which has a high prevalence of undiagnosed HIV in the Netherlands. The ultimate aim is to decrease the number of undiagnosed HIV in populations, improve the 90-90-90 HIV cascade of care goals particularly its first pillar, and to help supporting the UNAIDS goal to end HIV/AIDS

Study Design

Study Type:
Observational
Anticipated Enrollment :
1500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Supporting Health Care Professionals in Hospital and Primary Care to Promote Adequate HIV Risk and Indicator Condition Driven Testing in Routine Care.
Actual Study Start Date :
Jan 1, 2020
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Hospital

Medical specialists in hospitals and their patients aged 18 years and older in the participating hospitals who are diagnosed there with an HIV indicator condition.

Behavioral: Peer to peer feedback
HIV experts contact non-HIV specialised treating physicians on individual patient care to recommend HIV testing

Primary care

General practitioners and their patients aged 18 years and older in the participating general practices who are diagnosed there with an HIV indicator condition.

Behavioral: Peer to peer feedback
HIV experts contact non-HIV specialised treating physicians on individual patient care to recommend HIV testing

Diagnostic Test: HIV rapid test
Free HIV rapid tests are provided to non-HIV specialised treating physicians to use in individual patient care in patients at risk of HIV

Outcome Measures

Primary Outcome Measures

  1. The number of adequately performed HIV tests of identified HIV indicator conditions in relation to the total number of identified HIV indicator conditions by physicians in hospital settings during the project. [3 year]

  2. The number of adequately performed HIV tests of identified HIV indicator conditions in relation to the total number of identified HIV indicator conditions by general practitioners in primary care during the project. [3 year]

Secondary Outcome Measures

  1. The number of positive HIV tests in relation to the total number of HIV tests for identified HIV indicator conditions. [3 year]

  2. The percentage of adequately HIV tested patients per HIV indicator condition and per medical specialism. [31 year]

  3. The prevalence of HIV indicator conditions in primary care and hospitals. [3 year]

  4. The incidence of HIV indicator conditions in primary care and hospitals. [3 year]

  5. A sensitive and specific supervised artificial Intelligence tool that recognizes risk factors for HIV and HIV indicator conditions through natural language processing (NLP) and supports the hospital and primary care in proactive HIV testing policies. [3 year]

  6. Acceptance of HIV testing in by patients, medical specialist and in primary care. [3 year]

    Assessed by questionnaire

  7. The costs of pro-active HIV indicator case finding and relation to the savings and QALY's gained [3 year]

    Costs of the program in relation to the savings in costs and QALY's lost as a consequence of earlier HIV diagnosis with subsequent prevented HIV transmission, AIDS comorbidity and hospital admissions.

Other Outcome Measures

  1. The number of HIV tests in relation to the total number of HIV tests done by gender, ethnical background, age, previous HIV test and HIV indicator conditions of the patient, primary care setting and hospital setting. [3 year]

  2. Center for Disease Control and Prevention (CDC) HIV classification of the patients with an HIV positive test. [3 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of an HIV indicator conditions.
Exclusion Criteria:
  • Below 18 years of age

  • Recent HIV test (< 12 months, except for mononucleosis-like disease and STDs)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Carlijn CCE Jordans Rotterdam South-Holland Netherlands 3015GD

Sponsors and Collaborators

  • Erasmus Medical Center
  • Huisartspraktijk Gezondheidscentrum Mathenesserlaan
  • TU Delft department of Artificial Intelligence and MyTomorrows
  • Huisartsen Groep Rotterdam
  • AwareHIV Project Group
  • Huisartspraktijk Handellaan
  • Huisartspraktijk Leerdam
  • Huisartspraktijk Capelle ad IJssel
  • Leiden University Medical Center
  • Maasstadziekenhuis
  • Rijnstate Hospital
  • Medical Center Haaglanden

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Casper Rokx, MD PhD, Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT05225493
Other Study ID Numbers:
  • MEC-2021-0277
First Posted:
Feb 4, 2022
Last Update Posted:
Feb 4, 2022
Last Verified:
Jan 1, 2022

Study Results

No Results Posted as of Feb 4, 2022